Half of the patients who received an experimental vaccine for pancreas cancer being developed by Roche and BioNTech following ...

According to Roche subsidiary Genentech, which announced the label expansion on Monday, TNKase is the first new drug for ...

Illumina navigates competition and geopolitical risks with improved margins and strong cash flow. Read my analysis of ILMN ...

Genentech has had the lone medicine on the market for the acute treatment of stroke. | Over nearly the last three decades, ...

Submission is supported by positive results from the Phase III REGENCY trial, which demonstrated that nearly half of patients ...

Former Walton Family Enterprises CEO expands BanyanGlobal’s family office capabilities as the preeminent advisor to owners of ...

Roche’s Genentech unit has received approval from the US Food and Drug Administration (FDA) for TNKase (tenecteplase) in ...

Roche's Q4 results and innovative advancements make it a strong pick. Its late-stage pipeline supports our belief that there ...

Sebastian Roché tells PEOPLE that Harrison Ford is the "one actor" he'd regretted "not working with," so getting cast on ...

Genentech, a member of the Roche Group, announced new positive data from Stage 2 and Stage 3 of the National Institutes of Health-sponsored Phase III OUtMATCH study, which provide ...

The value that laboratories contribute to clinical decision-making is critical to the future of health care and enables ...

Posay, the dermatologist-recommended leader in skincare, is thrilled to announce its partnership with the BNP Paribas Open as ...